VACCINEX, INC.
VACCINEX, INC.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||||||||
Cash And Cash Equivalents At Carrying Value | 1 | 3 | 0 | 3 | 2 | 0 | 2 | 3 | 6 | 7 | 11 | 17 | |||||
Accounts Receivable Net Current | 1 | 1 | 1 | 3 | 1 | 1 | 0 | - | 0 | 0 | - | - | |||||
Assets Current | |||||||||||||||||
Assets Current | 3 | 5 | 2 | 7 | 3 | 2 | 3 | 4 | 7 | 8 | 12 | 18 | |||||
Prepaid Expense And Other Assets Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Derivative Assets Current | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - | - | - | |||||
Property Plant And Equipment Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Operating Lease Right Of Use Asset | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Assets | 3 | 5 | 2 | 7 | 4 | 3 | 3 | 5 | 8 | 9 | 13 | 18 | |||||
Liabilities And Stockhold… | |||||||||||||||||
Accounts Payable Current | 4 | 5 | 3 | 2 | 2 | 4 | 2 | 1 | 2 | 0 | 0 | 1 | |||||
Accrued Liabilities Current | 1 | 1 | 2 | 2 | 1 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | |||||
Liabilities Current | |||||||||||||||||
Liabilities Current | 5 | 6 | 5 | 5 | 6 | 6 | 3 | 2 | 3 | 2 | 1 | 2 | |||||
Contract With Customer Liability Current | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - | - | - | |||||
Long Term Debt Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Operating Lease Liability | - | - | - | - | - | - | - | - | - | - | 0 | 0 | |||||
Operating Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | |||||
Derivative Liabilities Current | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | - | - | - | - | |||||
Long Term Debt Noncurrent | 0 | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Operating Lease Liability Noncurrent | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | - | - | |||||
Liabilities | 5 | 6 | 5 | 5 | 6 | 6 | 4 | 2 | 3 | 2 | 2 | 2 | |||||
Stockholders Equity Inclu… | |||||||||||||||||
Preferred Stock Value | 2 | 2 | 1 | 1 | 0 | - | - | - | - | - | - | - | |||||
Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Additional Paid In Capital Common Stock | 354 | 352 | 345 | 345 | 338 | 333 | 331 | 327 | 325 | 321 | 321 | 321 | |||||
Treasury Stock Value | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | |||||
Retained Earnings Accumulated Deficit | -359 | -355 | -349 | -344 | -340 | -337 | -332 | -325 | -320 | -315 | -310 | -304 | |||||
Stockholders Equity | -2 | -1 | -3 | 3 | -2 | -4 | -0 | 2 | 5 | 6 | 11 | 16 | |||||
Liabilities And Stockholders Equity | 3 | 5 | 2 | 7 | 4 | 3 | 3 | 5 | 8 | 9 | 13 | 18 | |||||
Preferred Stock Par Or Stated Value Per Share | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | - | - | - | - | - | - | - | |||||
Preferred Stock Shares Authorized | 10 | 10 | 10 | 10 | 0 | - | - | - | - | - | - | - | |||||
Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - | - | - | |||||
Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - | - | - | |||||
Preferred Stock Liquidation Preference Value | 1,750 | 1,750 | 1,750 | 1,750 | 0 | - | - | - | - | - | - | - | |||||
Common Stock Par Or Stated Value Per Share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Shares Authorized | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | |||||
Common Stock Shares Issued | 3 | 3 | 2 | 2 | 1 | 5 | 4 | 4 | 0 | 3 | 3 | 3 | |||||
Shares Outstanding | 3 | 3 | - | 2 | 1 | 5 | 4 | 4 | 0 | 3 | 3 | 3 | |||||
Treasury Stock Common Shares | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | 31.97% | 17.94% | -7.10% | 8.27% | -50.96% | -43.27% | 7.12% | -67.12% | -67.12% | -21.84% | -1.15% | -19.54% |
| 2023 | 15.00% | -10.00% | -32.50% | -12.50% | -69.44% | -74.17% | -22.22% | -20.00% | -33.33% | -12.86% | -19.28% | -8.82% |
| 2022 | 7.63% | 0.00% | -12.71% | -31.78% | -44.86% | -46.73% | 10.17% | 8.47% | 0.00% | 0.00% | 0.00% | -5.00% |
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Metrics | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Metric history beyond 3 years is for subscribers only. Unlock 17+ years of history across 90+ calculated metrics Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 0.50 | 0.77 | 0.42 | 1.52 | 0.57 | 0.35 | 0.79 | 1.91 | 2.95 | 4.04 | 8.22 | 10.00 | |||||
| Quick Ratio | 0.38 | 0.63 | 0.25 | 1.24 | 0.42 | 0.17 | 0.57 | 1.44 | 2.59 | 3.64 | 7.65 | 9.46 | |||||
| Working Capital | -2.55M | -1.42M | -3.03M | 2.45M | -2.57M | -4.16M | -704.00K | 2.11M | 4.94M | 6.04M | 10.77M | 15.99M | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | -2.04 | -4.67 | -1.83 | 1.77 | -2.57 | -1.66 | -8.29 | 1.04 | 0.54 | 0.36 | 0.15 | 0.12 | |||||
| Interest Coverage TTM | - | - | - | -22,973.00 | -22,885.00 | -11,508.00 | -7,324.67 | -6,766.00 | -4,976.50 | -1,068.68 | -128.60 | -40.87 | |||||
| Debt Ratio | 1.96 | 1.27 | 2.21 | 0.64 | 1.64 | 2.51 | 1.14 | 0.51 | 0.35 | 0.27 | 0.13 | 0.11 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 0.19 | 0.10 | 0.13 | 0.02 | 0.10 | 0.14 | 0.11 | 0.07 | 0.03 | 0.00 | 0.00 | 0.00 | |||||
| Days Sales Outstanding TTM | 546.29 | 902.15 | 541.35 | 8,168.35 | 363.72 | 225.66 | 4.87 | - | 232.27 | 365.00 | - | - | |||||
| Receivables Turnover TTM | 0.67 | 0.40 | 0.67 | 0.04 | 1.00 | 1.62 | 75.00 | - | 1.57 | 1.00 | - | - | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | -8.88 | -9.17 | -9.77 | -14.46 | -43.68 | -68.33 | -75.97 | -84.97 | -98.05 | -6.81 | -6.96 | -7.89 | |||||
| Free Cash Flow Per Share TTM | -7.72 | -7.83 | -8.67 | -12.69 | -37.31 | -56.84 | -67.40 | -81.13 | -94.90 | -6.93 | -7.59 | -8.98 | |||||
| Dividend Per Share TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Margin Metrics | |||||||||||||||||
| Operating Profit Margin TTM | -3,117.30% | -5,241.24% | -6,072.47% | -18,526.61% | -4,014.91% | -2,895.09% | -2,663.52% | -2,460.36% | -7,238.55% | -40,610.00% | -41,152.00% | -41,688.00% | |||||
| Net Profit Margin TTM | -3,100.50% | -4,787.89% | -4,987.92% | -15,472.58% | -3,552.81% | -2,768.81% | -2,649.58% | -2,446.30% | -7,205.45% | -38,736.00% | -39,630.00% | -40,802.00% | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | 5.44% | -51.19% | -56.85% | -84.97% | 107.27% | 1,490.00% | 1,550.00% | 1,550.00% | -69.44% | -94.44% | -96.61% | -96.61% | |||||
| Net Income Growth (1Y) | -7.98% | -15.61% | -18.77% | -4.94% | 2.20% | 13.65% | 10.32% | -1.07% | -11.46% | -19.95% | -28.58% | -27.85% | |||||
| EPS Growth (1Y) | -79.67% | -86.59% | -87.14% | -82.99% | -55.46% | 903.42% | 991.08% | 976.69% | 743.07% | -42.18% | -52.16% | -47.05% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | -0.11 | -0.37 | -0.66 | -0.51 | -0.21 | -0.23 | -1.00 | -0.99 | -1.37 | -15.42 | -32.57 | -35.13 | |||||
| P/B TTM | -0.83 | -5.22 | -4.12 | 3.70 | -1.85 | -1.32 | -51.42 | 8.31 | 5.23 | 47.27 | 58.98 | 44.27 | |||||
| P/S TTM | 3.42 | 17.76 | 33.13 | 79.31 | 7.52 | 6.41 | 26.37 | 24.18 | 98.76 | 5,972.97 | 12,908.06 | 14,332.22 | |||||
| Market Cap | 2.06M | 6.89M | 11.80M | 9.83M | 4.28M | 5.10M | 21.75M | 19.95M | 27.16M | 298.65M | 645.40M | 716.61M | |||||
| Enterprise Value | 974.97K | 4.03M | 11.63M | 6.94M | 2.85M | 5.09M | 19.98M | 16.79M | 20.94M | 291.66M | 634.22M | 700.04M | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | -16.21M | -15.87M | -15.77M | -16.84M | -17.30M | -18.31M | -19.39M | -19.27M | -19.18M | -19.72M | -21.59M | -23.21M | |||||
| Net Debt | -1.08M | -2.86M | -170.00K | -2.89M | -1.43M | -8.00K | -1.77M | -3.17M | -6.22M | -6.99M | -11.19M | -16.57M | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
| NCAV | |||||||||||||||||
| NCAV Per Share TTM | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| PEG Ratio | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| EV Revenue TTM | |||||||||||||||||
| EV FCF TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
VACCINEX, INC. (VCNX) — SEC Financial Statements & Analysis
VACCINEX, INC. (VCNX) is a pharmaceutical preparations company, incorporated in DE. VACCINEX, INC. trades on OTC as: VCNX. Based on its latest SEC filing (Form 10-Q, period ending 2024-12-31), VACCINEX, INC. reported a 5.44% year-over-year revenue growth, a Debt-to-Equity ratio of -2.04x, a Price-to-Sales (P/S) ratio of 3.42x (TTM), a Price-to-Book (P/B) ratio of -0.83x (TTM), at a market cap of $2.06M. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- 5.44%
- Debt To Equity
- -2.04x
- P/S TTM
- 3.42x
- P/B TTM
- -0.83x
- Market Cap
- $2.06M
Data as of 2024-12-31 · Source: SEC EDGAR
Frequently Asked Questions
What industry is VACCINEX, INC. in?
VACCINEX, INC. (VCNX) operates in the Pharmaceutical Preparations industry.
What is VCNX's market cap?
VACCINEX, INC. (VCNX) has a market capitalization of $2.06M as of 2024-12-31.
What exchange does VCNX trade on?
VACCINEX, INC. (VCNX) trades on the OTC.
Where is VACCINEX, INC. incorporated?
VACCINEX, INC. is incorporated in DE.